CClinicalTrials.gg
Enrolling by invitationNCT06687044Updated Nov 13, 2024

Sleep Improvement Therapy Affects Pregnancy Outcomes in Chinese Singletons and Twins by Improving Sleep Quality

An interventional study of Sleep restriction and Stimulation control in Gestational Diabetes, Hypertension in Pregnancy and Preterm Labor, sponsored by Jun Wei. Enrolling by invitation at 1 site in China. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-13.

Sponsored by Jun Wei · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

During pregnancy, the physical and psychological changes of pregnant women, hyperemesis gravidarum, uterine compression, frequent urination, hip or pelvic pain, back pain, leg cramps, gastroesophageal reflux, changes in mental state, and even changes in lifestyle, habits and tastes may affect the sleep of pregnant women. Due to the coexistence of physiological, psychological, social and other complex factors during pregnancy, the incidence of sleep disorders in pregnant women is relatively high, up to 50%, and shows an increasing trend with the increase of gestational week. Not only seriously affect the quality of life of pregnant women, but also may lead to a variety of pregnancy complications, and even lead to adverse pregnancy outcomes. Therefore, early identification, timely diagnosis and treatment of sleep disorders during pregnancy are important measures to improve or even reverse adverse pregnancy outcomes. Although sleep disorders are more common and seriously harmful during pregnancy, people lack of understanding and attention to such diseases, and often regard them as normal clinical manifestations of pregnancy and neglect diagnosis and treatment.

Studies have shown that maternal sleep disorders are associated with hypertensive disorders during pregnancy, preterm birth, and gestational diabetes. Current research objects mainly focus on single pregnancy, twin related research is less.

The purpose of this study is to explore the perinatal sleep health of pregnant women with twin pregnancies, reduce the complications of pregnant women with twin pregnancies and improve the pregnancy outcomes of mothers and infants by improving sleep quality.

02

Conditions studied

  • Gestational Diabetes
  • Hypertension in Pregnancy
  • Preterm Labor
  • NICU Infants
03

In context

Diabetes, Gestational

842 studies on the registry are indexed under Diabetes, Gestational; 198 are open to participants now.

This study's planned enrollment of 300 is above the median of 110 across 550 interventional studies indexed under Diabetes, Gestational.

Browse Diabetes, Gestational studies →

Lead sponsor

This is the only study on the registry with Jun Wei as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: (1) Pregnant women aged 18-45 years. (2) Diagnosed with single or twin pregnancy within 12 weeks of pregnancy, report sleep quality problems, agree to participate in the study and sign the informed consent -

Exclusion Criteria:Have a prior serious underlying medical condition (e.g., diabetes, heart disease), mental illness, or other serious sleep disorder

-

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Sleep improvement Therapy group(CBT-I)

    Behavioral: Sleep restriction · Behavioral: Stimulation control · Behavioral: Cognitive therapy

  • Placebo comparator
    Control group (TAU)

    Behavioral: Sleep principles discussion

Interventions

  • BehavioralSleep restriction

    Go to bed before 23pm

  • BehavioralStimulation control

    Avoid drugs, alcohol, caffeine, and nicotine

  • BehavioralCognitive therapy

    Listen to 30 minutes of soothing music every night for 8 weeks

  • BehavioralSleep principles discussion

    The principles of sleep hygiene are discussed, but without the application of stimulus control or sleep restriction

06

What researchers measure

Primary outcomes

  1. Hypertension in pregnancy

    Pregnancy induced hypertension (PIH) is hypertension that occurs after 20 weeks of gestation in women with previously normal blood pressure.

    Time frame: From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)

  2. Gestational diabetes mellitus

    Gestational diabetes mellitus (GDM) is defined as glucose intolerance of variable degree with onset or first recognition during pregnancy

    Time frame: From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)

  3. Preterm labor

    Preterm labor is parturition that occurs when birth occurs between 28 weeks of gestation and 37 weeks

    Time frame: From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)

  4. NICU infants

    Neonatal NICU occupancy rate

    Time frame: From the data of randomization until the date of the end of this pregnancy (up to 50 weeks)

07

Study locations

1 site
  • Shengjing Hospital of China Medical University
    Shenyang, Liaoning 110004, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06687044
Lead sponsor
Jun Wei
Responsible party
Jun Wei (Department of Gynecology and Obstetrics, Shengjing Hospital) — Sponsor-investigator
First posted
Nov 13, 2024
Start date
Nov 1, 2024
Primary completion
Nov 1, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Nov 13, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion